SightfileU.S. market data from official filings

Companies › IMVT

IMMUNOVANT INC (IMVT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001764013 · EDGAR filings · Updated 2026-07-24

IMMUNOVANT INC (IMVT) has reported institutional ownership of 53.9%, with 216 institutional managers holding positions valued at $2.75B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
53.9%
Institutional managers
216
Reported 13F value
$2.75B
Insider activity
47 trans.
$347.1M net buying
Data flags
1 active
from SEC filings

Filings this week (6)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IMMUNOVANT INC has 216 institutional holders and institutional ownership of 53.9%.

Insider activity

Insiders reported 47 transactions (1 buys, 32 sells) across 15 reporting insiders, with a net reported value of $347.1M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2020-02-14 (recurring since 2020-02-14) — source filing. The authoritative details are those stated in the filing itself.

Related companies

VERACYTE INC (VCYT) · DENALI THERAPEUTICS INC (DNLI) · CARIS LIFE SCIENCES INC (CAI) · DISC MEDICINE INC (IRON) · HAEMONETICS CORP MASS (HAE) · 10X GENOMICS INC (TXG)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.